Poly(l-glutamic acid)-b-poly(N
γ-acetyl-l-2,4-diaminobutyric
acid), P(Glu-b-NADA), amphiphilic block-co-polypeptides with different hydrophobic/hydrophilic ratios were
synthesized as drug carriers for dermal delivery. The block-co-polypeptides were prepared using ring-opening polymerization
(ROP) of γ-benzyl l-glutamate N-carboxyanhydride
and polycondensation of the activated urethane derivative of N
γ-acetyl-l-2,4-diaminobutyric
acid. Structures and conjugations of two blocks were successfully
confirmed by 1H NMR, FTIR, DOSY NMR, GPC, and TGA. The
nanocarriers were loaded with 5,10,15,20-tetrakis(3-hydroxyphenyl)porphyrin
(m-THPP), a close congener of the approved photosensitizer
5,10,15,20-tetrakis(3-hydroxyphenyl)chlorin (m-THPC, temoporfin),
and the loading capacity was found to be dependent on the composition
of the block-co-polypeptides. Among the synthesized
polymers, P(Glu55-b-NADA20)
with moderate hydrophobic content showed the highest drug loading
capacity of 4 wt % and self-aggregated into spherical nanoparticles
with a size of 180–200 nm, which was confirmed by TEM and DLS.
In an in vitro drug release study, P(Glu55-b-NADA20) could release m-THPP in a controllable manner. Furthermore, the synthesized polymer
P(Glu55-b-NADA20) did not show
high toxicity against HaCaT and HeLa cells up to 1000 and 500 μg
mL–1, respectively, in an in vitro cell viability assay. Finally, it was shown in an ex vivo skin penetration study that the ionic amphiphilic block co-polypeptide
enhanced the m-THPP penetration into human skin compared
to base cream up to a factor of 12. m-THPP was released from P(Glu55-b-NADA20) to the viable epidermis
while the polymer was deposited in the skin’s stratum corneum.
Taking advantage of its excellent biodegradability, the low cytotoxcity,
and efficient skin penetration, the synthesized block-co-polypeptide has the potential for future topical delivery systems.